Total Valuation
Eckert & Ziegler Strahlen und Medizintechnik has a market cap or net worth of €824.72M. The enterprise value is €892.81.
Market Cap€824.72M
Enterprise Value€892.81
Share Statistics
Eckert & Ziegler Strahlen und Medizintechnik has 63,515,797 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,515,797
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Eckert & Ziegler Strahlen und Medizintechnik’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 11.99%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)11.99%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee282.32K
Profits Per Employee44.55K
Employee Count1,105
Asset Turnover0.64
Inventory Turnover3.58
Valuation Ratios
The current PE Ratio of Eckert & Ziegler Strahlen und Medizintechnik is 16.3. Eckert & Ziegler Strahlen und Medizintechnik’s PEG ratio is 0.41.
PE Ratio16.3
PS Ratio3.06
PB Ratio3.79
Price to Fair Value3.79
Price to FCF27.76
Price to Operating Cash Flow16.04
PEG Ratio0.41
Income Statement
In the last 12 months, Eckert & Ziegler Strahlen und Medizintechnik had revenue of 311.96M and earned 48.76M in profits. Earnings per share was 0.78.
Revenue311.96M
Gross Profit147.21M
Operating Income75.06M
Pretax Income72.77M
Net Income48.76M
EBITDA92.13M
Earnings Per Share (EPS)0.78
Cash Flow
In the last 12 months, operating cash flow was 51.61M and capital expenditures -25.52M, giving a free cash flow of 26.09M billion.
Operating Cash Flow51.61M
Free Cash Flow26.09M
Free Cash Flow per Share0.41
Dividends & Yields
Eckert & Ziegler Strahlen und Medizintechnik pays an annual dividend of €0.22, resulting in a dividend yield of 1.67%
Dividend Per Share€0.22
Dividend Yield1.67%
Payout Ratio27.85%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.21
52-Week Price Change-23.93%
50-Day Moving Average14.30
200-Day Moving Average14.83
Relative Strength Index (RSI)32.99
Average Volume (3m)9.92K
Important Dates
Eckert & Ziegler Strahlen und Medizintechnik upcoming earnings date is Nov 12, 2026, TBA (Confirmed).
Last Earnings DateAug 13, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
Eckert & Ziegler Strahlen und Medizintechnik as a current ratio of 3.45, with Debt / Equity ratio of 15.24%
Current Ratio3.45
Quick Ratio2.81
Debt to Market Cap0.01
Net Debt to EBITDA-0.91
Interest Coverage Ratio38.67
Taxes
In the past 12 months, Eckert & Ziegler Strahlen und Medizintechnik has paid 23.54M in taxes.
Income Tax23.54M
Effective Tax Rate0.32
Enterprise Valuation
Eckert & Ziegler Strahlen und Medizintechnik EV to EBITDA ratio is 9.45, with an EV/FCF ratio of 25.33.
EV to Sales2.79
EV to EBITDA9.45
EV to Free Cash Flow25.33
EV to Operating Cash Flow14.42
Balance Sheet
Eckert & Ziegler Strahlen und Medizintechnik has €110.33M in cash and marketable securities with €41.04M in debt, giving a net cash position of €69.29M billion.
Cash & Marketable Securities€110.33M
Total Debt€41.04M
Net Cash€69.29M
Net Cash Per Share€1.09
Tangible Book Value Per Share€3.32
Margins
Gross margin is 46.87%, with operating margin of 24.06%, and net profit margin of 15.63%.
Gross Margin46.87%
Operating Margin24.06%
Pretax Margin23.33%
Net Profit Margin15.63%
EBITDA Margin29.53%
EBIT Margin24.06%
Analyst Forecast
The average price target for Eckert & Ziegler Strahlen und Medizintechnik is €22.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€22.00
Price Target Upside66.29% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast4.42%
EPS Growth Forecast35.68%